Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
$ 0
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
About
A technology-based specialty pharmaceutical company focused on the development, manufacturing, and commercialization of controlled drug delivery systems, generic formulations, and branded pharmaceutical products across two main segments: Impax Generics and Impax Specialty Pharma
